| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-23602SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-90243-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-52447-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-38487-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-14350-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-93937-0.02ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-52448-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76542-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-37868-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | MAB35262-SP | |||
![Immunocytochemistry/Immunofluorescence: GLI-2 Antibody [NBP2-23602] - HeLa cells were fixed in 4% paraformaldehyde for 10 minutes and permeabilized in 0.5% Triton X-100 in PBS for 5 minutes. The cells were incubated with GLI-2 Antibody (NBP2-23602) at 1 ug/ml overnight at 4C and detected with an anti-rabbit Dylight 488 (Green) at a 1:1000 dilution for 60 minutes. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 100X objective and digitally deconvolved.](http://images.novusbio.com/fullsize/GLI-2-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-23602-img0007.jpg "Immunocytochemistry/Immunofluorescence: GLI-2 Antibody [NBP2-23602] - HeLa cells were fixed in 4% paraformaldehyde for 10 minutes and permeabilized in 0.5% Triton X-100 in PBS for 5 minutes. The cells were incubated with GLI-2 Antibody (NBP2-23602) at 1 ug/ml overnight at 4C and detected with an anti-rabbit Dylight 488 (Green) at a 1:1000 dilution for 60 minutes. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 100X objective and digitally deconvolved.")
![Immunohistochemistry-Paraffin: GLI-2 Antibody [NBP2-23602] - GLI-2 (red) and DAPI (blue) in mouse BT-474 primary tumors (breast cancer tissue). IHC-P image submitted by a verified customer review.](http://images.novusbio.com/fullsize/GLI-2-Antibody-Immunohistochemistry-Paraffin-NBP2-23602-img0006.jpg)
![Immunocytochemistry/Immunofluorescence: GLI-2 Antibody [NBP2-23602] - GLI-2 antibody was tested in HeLa cells with DyLight 488 (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and DyLight 550 (red). An antibody dilution of 1:50 was used. Image objective 40x.](http://images.novusbio.com/fullsize/GLI-2-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-23602-img0004.jpg)
![Immunohistochemistry: GLI-2 Antibody [NBP2-23602] - Analysis of GLI-2 in mouse heart.](http://images.novusbio.com/fullsize/GLI-2-Antibody-Immunohistochemistry-NBP2-23602-img0005.jpg)
![Western Blot: G-CSF Antibody (7E4F7) [NBP2-52447] - Analysis using CSF3 mAb against human CSF3 (AA: 1-207) recombinant protein. (Expected MW is 48.2 kDa)](http://images.novusbio.com/fullsize/G-CSF-Antibody-7E4F7-Western-Blot-NBP2-52447-img0004.jpg "Western Blot: G-CSF Antibody (7E4F7) [NBP2-52447] - Analysis using CSF3 mAb against human CSF3 (AA: 1-207) recombinant protein. (Expected MW is 48.2 kDa)")
![Immunocytochemistry/Immunofluorescence: G-CSF Antibody (7E4F7) [NBP2-52447] - Immunofluorescence analysis of A549 cells using CSF3 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.](http://images.novusbio.com/fullsize/G-CSF-Antibody-7E4F7-Immunofluorescence-NBP2-52447-img0001.jpg)
![Immunohistochemistry: G-CSF Antibody (7E4F7) [NBP2-52447] - Analysis of paraffin-embedded esophageal cancer tissues using CSF3 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/G-CSF-Antibody-7E4F7-Immunohistochemistry-NBP2-52447-img0003.jpg)
![Western Blot: G-CSF Antibody (7E4F7) [NBP2-52447] - Analysis using CSF3 mAb against HEK293 (1) and CSF3 (AA: 1-207)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/G-CSF-Antibody-7E4F7-Western-Blot-NBP2-52447-img0005.jpg)
![Immunohistochemistry: G-CSF Antibody (7E4F7) [NBP2-52447] - Analysis of Hela cells using CSF3 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.](http://images.novusbio.com/fullsize/G-CSF-Antibody-7E4F7-Immunohistochemistry-NBP2-52447-img0002.jpg)
![ELISA: G-CSF Antibody (7E4F7) [NBP2-52447] - Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng).](http://images.novusbio.com/fullsize/G-CSF-Antibody-7E4F7-ELISA-NBP2-52447-img0006.jpg)
![Western Blot: PARD6A Antibody [NBP2-38487] - Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10. Lane 2: Human cell line RT-4. Lane 3: Human cell line U-251MG](http://images.novusbio.com/fullsize/PARD6A-Antibody-Western-Blot-NBP2-38487-img0002.jpg "Western Blot: PARD6A Antibody [NBP2-38487] - Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10. Lane 2: Human cell line RT-4. Lane 3: Human cell line U-251MG")
![Immunocytochemistry/Immunofluorescence: PARD6A Antibody [NBP2-38487] - Staining of human cell line MCF7 shows localization to actin filaments & cell junctions. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/PARD6A-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-38487-img0003.jpg)
![Immunohistochemistry-Paraffin: PARD6A Antibody [NBP2-38487] - Staining of human testis shows moderate membranous positivity in cells in seminiferous ducts.](http://images.novusbio.com/fullsize/PARD6A-Antibody-Immunohistochemistry-Paraffin-NBP2-38487-img0008.jpg)
![Immunohistochemistry-Paraffin: PARD6A Antibody [NBP2-38487] - Staining of human cerebellum shows strong cytoplasmic positivity in Purkinje cells.](http://images.novusbio.com/fullsize/PARD6A-Antibody-Immunohistochemistry-Paraffin-NBP2-38487-img0005.jpg)
![Immunohistochemistry-Paraffin: PARD6A Antibody [NBP2-38487] - Staining of human kidney shows strong membranous positivity](http://images.novusbio.com/fullsize/PARD6A-Antibody-Immunohistochemistry-Paraffin-NBP2-38487-img0006.jpg)
![Immunohistochemistry-Paraffin: PARD6A Antibody [NBP2-38487] - Staining of human liver shows no positivity in hepatocytes as expected.](http://images.novusbio.com/fullsize/PARD6A-Antibody-Immunohistochemistry-Paraffin-NBP2-38487-img0007.jpg)
![Western Blot: BCL9-2 Antibody [NBP2-14350] - Analysis in human cell lines A-549 and HEK293 using anti-BCL9L antibody. Corresponding BCL9L RNA-seq data are presented for the same cell lines. Loading control: anti-HDAC1.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Western-Blot-NBP2-14350-img0010.jpg "<b>Orthogonal Strategies Validation. </b>Western Blot: BCL9-2 Antibody [NBP2-14350] - Analysis in human cell lines A-549 and HEK293 using anti-BCL9L antibody. Corresponding BCL9L RNA-seq data are presented for the same cell lines. Loading control: anti-HDAC1.")
![<b>Orthogonal Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: BCL9-2 Antibody [NBP2-14350] - Staining of human cell line CACO-2 shows localization to nucleoplasm. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-14350-img0005.jpg)
![Immunohistochemistry-Paraffin: BCL9-2 Antibody [NBP2-14350] - Staining of human liver shows no positivity in hepatocytes as expected.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Immunohistochemistry-Paraffin-NBP2-14350-img0016.jpg)
![Immunohistochemistry-Paraffin: BCL9-2 Antibody [NBP2-14350] - Staining of human breast shows moderate to strong nuclear positivity in glandular cells.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Immunohistochemistry-Paraffin-NBP2-14350-img0012.jpg)
![Immunohistochemistry-Paraffin: BCL9-2 Antibody [NBP2-14350] - Staining of human testis shows moderate nuclear positivity in cells in seminiferous ducts.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Immunohistochemistry-Paraffin-NBP2-14350-img0013.jpg)
![Immunohistochemistry-Paraffin: BCL9-2 Antibody [NBP2-14350] - Staining of human placenta shows moderate to strong nuclear positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Immunohistochemistry-Paraffin-NBP2-14350-img0015.jpg)
![Western Blot: PRL-2/PTP4A2 Antibody [NBP2-93937] - Analysis of extracts of various cell lines, using PRL-2/PTP4A2 at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit . Exposure time: 30s.](http://images.novusbio.com/fullsize/PRL-2-PTP4A2-Antibody-Western-Blot-NBP2-93937-img0005.jpg "Western Blot: PRL-2/PTP4A2 Antibody [NBP2-93937] - Analysis of extracts of various cell lines, using PRL-2/PTP4A2 at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit . Exposure time: 30s.")
![Immunocytochemistry/Immunofluorescence: PRL-2/PTP4A2 Antibody [NBP2-93937] - Analysis of C6 cells using PRL-2/PTP4A2 at dilution of 1:100. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/PRL-2-PTP4A2-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-93937-img0001.jpg)
![Immunohistochemistry-Paraffin: PRL-2/PTP4A2 Antibody [NBP2-93937] - Rat kidney using PTP4A2 antibody at dilution of 1:100 (40x lens).Perform microwave antigen retrieval with 10 mM PBS buffer pH 7.2 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/PRL-2-PTP4A2-Antibody-Immunohistochemistry-Paraffin-NBP2-93937-img0004.jpg)
![Immunohistochemistry-Paraffin: PRL-2/PTP4A2 Antibody [NBP2-93937] - Human colon using PTP4A2 antibody at dilution of 1:100 (40x lens).Perform microwave antigen retrieval with 10 mM PBS buffer pH 7.2 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/PRL-2-PTP4A2-Antibody-Immunohistochemistry-Paraffin-NBP2-93937-img0002.jpg)
![Immunohistochemistry-Paraffin: PRL-2/PTP4A2 Antibody [NBP2-93937] - Mouse lung using PTP4A2 antibody at dilution of 1:100 (40x lens).Perform microwave antigen retrieval with 10 mM PBS buffer pH 7.2 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/PRL-2-PTP4A2-Antibody-Immunohistochemistry-Paraffin-NBP2-93937-img0003.jpg)
![Western Blot: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis using CSF3 mAb against human CSF3 (AA: 1-207) recombinant protein. (Expected MW is 48.2 kDa)](http://images.novusbio.com/fullsize/G-CSF-Antibody-8G5F7-Western-Blot-NBP2-52448-img0004.jpg "Western Blot: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis using CSF3 mAb against human CSF3 (AA: 1-207) recombinant protein. (Expected MW is 48.2 kDa)")
![Immunocytochemistry/Immunofluorescence: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis of Hela cells using CSF3 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.](http://images.novusbio.com/fullsize/G-CSF-Antibody-8G5F7-Immunofluorescence-NBP2-52448-img0003.jpg)
![Flow Cytometry: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis of A549 cells using CSF3 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/G-CSF-Antibody-8G5F7-Flow-Cytometry-NBP2-52448-img0001.jpg)
![Western Blot: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis using CSF3 mAb against HEK293 (1) and CSF3 (AA: 1-207)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/G-CSF-Antibody-8G5F7-Western-Blot-NBP2-52448-img0005.jpg)
![Immunocytochemistry/Immunofluorescence: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis of A549 cells using CSF3 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.](http://images.novusbio.com/fullsize/G-CSF-Antibody-8G5F7-Immunofluorescence-NBP2-52448-img0002.jpg)
![ELISA: G-CSF Antibody (8G5F7) [NBP2-52448] - Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng).](http://images.novusbio.com/fullsize/G-CSF-Antibody-8G5F7-ELISA-NBP2-52448-img0006.jpg)
![Western Blot: PARD6A Antibody [NB300-953] - (2ug/ml) staining of Jurkat (A) and U251 (B) cell lysate (35ug protein in RIPA buffer). Detected by chemiluminescence.](http://images.novusbio.com/fullsize/PARD6A-Antibody-Western-Blot-NB300-953-img0006.jpg "Western Blot: PARD6A Antibody [NB300-953] - (2ug/ml) staining of Jurkat (A) and U251 (B) cell lysate (35ug protein in RIPA buffer). Detected by chemiluminescence.")
![Immunohistochemistry-Paraffin: PARD6A Antibody [NB300-953] - (10ug/ml) staining of paraffin embedded Human Human Pancreas. Microwaved antigen retrieval with Tris/EDTA buffer pH9, HRP-staining.](http://images.novusbio.com/fullsize/PARD6A-Antibody-Immunohistochemistry-Paraffin-NB300-953-img0005.jpg)
![Flow Cytometry: PARD6A Antibody [NB300-953] - Analysis of paraformaldehyde fixed Jurkat cells (blue line), permeabilized with 0.5% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (1ug/ml). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/PARD6A-Antibody-Flow-Cytometry-NB300-953-img0007.jpg)
![Immunohistochemistry-Paraffin: PARD6A Antibody [NB300-953] - (5ug/ml) staining of paraffin embedded Human Heart. Steamed antigen retrieval with citrate buffer pH 6, AP-staining.](http://images.novusbio.com/fullsize/PARD6A-Antibody-Immunohistochemistry-Paraffin-NB300-953-img0004.jpg)
![Western Blot: BCL9-2 Antibody [NBP1-76542] - HeLa cell lysate at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Western-Blot-NBP1-76542-img0004.jpg "Western Blot: BCL9-2 Antibody [NBP1-76542] - HeLa cell lysate at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.")
![Immunocytochemistry/ Immunofluorescence: BCL9-2 Antibody - BSA Free [NBP1-76542] - Immunofluorescence of BCL9-2 in human breast tissue with BCL9-2 antibody at 20 ug/ml.Green: BCL9-2 Antibody Blue: DAPI staining](http://images.novusbio.com/fullsize/nbp1-76542_rabbit-polyclonal-bcl9-2-antibody-2711202420405548.gif)
![Immunohistochemistry: BCL9-2 Antibody [NBP1-76542] - Staining of Bcl9L in human breast tissue with Bcl9L antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Immunohistochemistry-NBP1-76542-img0006.jpg)
![Immunocytochemistry/ Immunofluorescence: BCL9-2 Antibody - BSA Free [NBP1-76542] - Immunocytochemistry of BCL9-2 in HeLa cells with BCL9-2 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76542_rabbit-polyclonal-bcl9-2-antibody-27112024204564.jpg)
![Immunocytochemistry/Immunofluorescence: Mxi1 Antibody (PCRP-MXI1-1A3) [NBP3-08353] - Immunofluorescence analysis of PFA-fixed HeLa cells. Mxi1 Mouse Monoclonal Antibody (PCRP-Mxi1-1A3)](http://images.novusbio.com/fullsize/Mxi1-Antibody-PCRP-MXI1-1A3-Immunocytochemistry-Immunofluorescence-NBP3-08353-img0002.jpg "Immunocytochemistry/Immunofluorescence: Mxi1 Antibody (PCRP-MXI1-1A3) [NBP3-08353] - Immunofluorescence analysis of PFA-fixed HeLa cells. Mxi1 Mouse Monoclonal Antibody (PCRP-Mxi1-1A3)")
![Flow Cytometry: Mxi1 Antibody (PCRP-MXI1-1A3) [NBP3-08353] - Flow Cytometric Analysis of PFA-fixed HeLa cells. Mxi1 Mouse Monoclonal Antibody (PCRP-Mxi1-1A3) followed by goat anti- Mouse IgG-CF488 (blue); unstained cells (red).](http://images.novusbio.com/fullsize/Mxi1-Antibody-PCRP-MXI1-1A3-Flow-Cytometry-NBP3-08353-img0001.jpg)
![Protein Array: Mxi1 Antibody (PCRP-MXI1-1A3) [NBP3-08353] - Analysis of Protein Array containing more than 19,000 full-length human proteins using Mxi1 Mouse Monoclonal Antibody (PCRP-Mxi1-1A3).](http://images.novusbio.com/fullsize/Mxi1-Antibody-PCRP-MXI1-1A3-Protein-Array-NBP3-08353-img0003.jpg)
![Immunohistochemistry-Paraffin: LRP-5 Antibody [NBP2-37868] - Staining of human liver shows strong cytoplasmic positivity in hepatocytes.](http://images.novusbio.com/fullsize/LRP-5-Antibody-Immunohistochemistry-Paraffin-NBP2-37868-img0005.jpg "Immunohistochemistry-Paraffin: LRP-5 Antibody [NBP2-37868] - Staining of human liver shows strong cytoplasmic positivity in hepatocytes.")
![Immunohistochemistry-Paraffin: LRP-5 Antibody [NBP2-37868] - Staining of human liver shows strong cytoplasmic positivity in hepatocytes.](http://images.novusbio.com/fullsize/LRP-5-Antibody-Immunohistochemistry-Paraffin-NBP2-37868-img0002.jpg)
![Immunohistochemistry-Paraffin: LRP-5 Antibody [NBP2-37868] - Staining of human cerebellum shows no positivity in neurons as expected.](http://images.novusbio.com/fullsize/LRP-5-Antibody-Immunohistochemistry-Paraffin-NBP2-37868-img0003.jpg)
![Immunohistochemistry-Paraffin: LRP-5 Antibody [NBP2-37868] - Staining of human kidney shows strong cytoplasmic positivity in cells in tubules.](http://images.novusbio.com/fullsize/LRP-5-Antibody-Immunohistochemistry-Paraffin-NBP2-37868-img0004.jpg)
![Immunohistochemistry-Paraffin: GLI-2 Antibody (524409) [Unconjugated] [MAB35262] - GLI-2 was detected in immersion fixed paraffin-embedded sections of human squamous cell carcinoma using Mouse Anti-Human GLI-2 Monoclonal Antibody (Catalog # MAB35262) at 5 ug/mL for 1 hour at room temperature followed by incubation with the Anti-Mouse IgG VisUCyte HRP Polymer Antibody (Catalog # VC001). Before incubation with the primary antibody, tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (Catalog # CTS013). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to cell nuclei. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.](http://images.novusbio.com/fullsize/GLI-2-Antibody-524409-Unconjugated-Immunohistochemistry-Paraffin-MAB35262-img0001.jpg "Immunohistochemistry-Paraffin: GLI-2 Antibody (524409) [Unconjugated] [MAB35262] - GLI-2 was detected in immersion fixed paraffin-embedded sections of human squamous cell carcinoma using Mouse Anti-Human GLI-2 Monoclonal Antibody (Catalog # MAB35262) at 5 ug/mL for 1 hour at room temperature followed by incubation with the Anti-Mouse IgG VisUCyte HRP Polymer Antibody (Catalog # VC001). Before incubation with the primary antibody, tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (Catalog # CTS013). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to cell nuclei. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.")